Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

NCT00372307 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT00372307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2004
Completion date
November 30, 2004
Enrollment
26
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo vulgaris